Research Article
Synovial Sarcoma of the Head and Neck: A Single Institution Review
Table 2
Comparison of median survival times.
| Variable | Median PFS duration, years | Log-rank test value | Median OS duration, years | Log-rank test value |
| Sex | | | | | Male | 5.41 | 0.21 | NA | 0.87 | Female | 3.47 | | NA | | Race | | | | | White | NA | 0.38 | 7.28 | 0.09 | Other | 4.18 | | NA | | Tumor size | | | | | ≥5 cm | 3.33 | 0.008 | NA | 0.78 | <5 cm | NA | | NA | | Subtype | | | | | Monophasic | 4.17 | 0.745 | 7.9 | 1.00 | Biphasic | NA | | NA | | Poorly differentiated | 5.41 | | 7.22 | | Surgical margin | | | | | Positive | NA | 0.52 | NA | 0.98 | Margin | NA | | NA | | Fusion gene | | | | | Present | 4.02 | | NA | | Site | | | | | Neck | 3.47 | 0.04 | 7.28 | 0.27 | Other | NA | | NA | | Treatment | | | | | Definitive local therapy | 5.41 | 0.78 | NA | 0.80 | Local + systemic therapy | 4.58 | | NA | |
|
|
Note. “NA” indicates that median survival was not reached; PFS: progression-free survival; OS: overall survival.
|